NCT06636214 · NOT YET RECRUITING
Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive
This trial is testing an updated version of a staff communication training program called CHATO, adapted to work better in nursing homes with diverse staff and residents. It is a behavioral intervention — no drugs involved. Researchers will train nursing home staff and then look at whether residents with dementia fare better as a result. Phase NA means this is likely a real-world feasibility or effectiveness study, not a standard drug-phase trial.
You may qualify if
- Medicare certified NHs (N=40) caring for 75% White, non-Hispanic residents, and care for residents diagnosed with AD/ADRD.
- CNAs, nurses, and other direct care staff who are permanent employees of participating NHs and who provide direct care at least 8 hours weekly will complete the CHATO-I training, available by URL link.
- All staff will be encouraged to participate as high staff participation is desired to achieve facility-wide communication change. NHs will provide the number of eligible staff participants.
- Data for residents in participating NHs with AD/ADRD documented on the MDS Active Diagnoses list will be included in the analyses as well as MDS data for: age, sex, race and ethnicity, frailty (MDS-CHESS scale), and level of cognitive function (MDS Cognitive Performance Scale).
You're excluded if
- NHs serving 25% of residents admitted prior to age 65 will be excluded (screening out NHs serving primarily younger persons with serious mental illnesses).
- CNAs, nurses, and other direct care staff who do not meet the inclusion criteria. Resident Sample.
- Resident data excluded from MDS includes active psychiatric diagnoses (bipolar disorder, major depressive episode, schizophrenia or schizoaffective disorder, mood disorder with psychotic features, psychotic symptoms, hallucinations, or delusions); terminal illness (on hospice); and lack of response to staff (MDS section B).
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-08-11